4610126387!
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- SPE2D226D0001
- Awardee
-
Avkare LLC UEI SFPGXE6XPS93
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Task orders
- 0
Award facts
- Opportunity
-
- Potassium Chloride Extended Release Tablets Pre-Solicitation · SPE2D224R0013 · Posted May 14, 2024
- Last date to order 21% complete
- IDV ceiling
- $39,510,148.75
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Avkare LLC, a pharmaceutical and medical supply distributor based in Pulaski, Tennessee, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency (DLA) Troop Support Medical with a ceiling value of $39.51 million and a period of performance extending from October 16, 2025, through October 15, 2030. This unrestricted, fully competitive procurement supports the DLA Medical Supply Chain, a defense-oriented federal agency, and establishes Avkare as a prime vendor for pharmaceutical products to federal healthcare beneficiaries. The contract was issued following a pre-solicitation notice posted on May 14, 2024, for a national requirements contract for Potassium Chloride Extended Release Tablets in 10 milliequivalent and 20 milliequivalent formulations. The original solicitation, issued as a firm-fixed price requirements contract under Federal Acquisition Regulation Part 12 as a commercial item, structured the acquisition with a one-year base period and four one-year renewal options, with annual usage estimates to be detailed in the Schedule of Supplies section of the formal solicitation documents.
This award reinforces Avkare's established position within the federal pharmaceutical supply chain, complementing the company's substantial existing portfolio of Indefinite Delivery Contracts with the Department of Veterans Affairs, Department of Defense, and Defense Logistics Agency. Avkare's existing contracts include a $1.637 billion Federal Supply Schedule contract with the General Services Administration and multiple specialized pharmaceutical IDCs valued between $9 million and $90.7 million for medications including Metformin Hydrochloride, Mycophenolate Mofetil, Abiraterone Acetate, and various other generic prescription products. The Potassium Chloride Extended Release Tablets contract enables the DLA to issue task and delivery orders on an as-needed basis to support the pharmaceutical requirements of federal healthcare organizations, including the Department of Defense, Department of Veterans Affairs, Bureau of Prisons, and Indian Health Service, under the established prime vendor program framework.
Quick answers
Who was awarded contract SPE2D226D0001?
SPE2D226D0001 was awarded to Avkare LLC by Medical Supply Chain (Troop Support) on October 16, 2025.
How much is contract SPE2D226D0001 worth?
SPE2D226D0001's own ceiling is $39,510,149.
Who can order from contract SPE2D226D0001?
SPE2D226D0001 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract SPE2D226D0001 competed?
The extent of competition for SPE2D226D0001 was full and open competition. The government received 6 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV